Patents by Inventor Amir Dori

Amir Dori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION
    Publication number: 20230190887
    Abstract: Testing peptides in in vitro models of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Frontotemporal dementia, Amyotrophic lateral sclerosis, to evaluate systems and methods of treatment therefore.
    Type: Application
    Filed: November 18, 2022
    Publication date: June 22, 2023
    Applicants: University of South Carolina, Ramot at Tel-Aviv University Ltd., Tel HaShomer Medical Research Infrastructure and Services Ltd.
    Inventors: Amar N. Kar, Pabitra Sahoo, Jeffery Twiss, Sean McGill, Eran Perlson, Topaz Altman, Ariel Razvan Ionescu, Tal Gradus-Pery, Amir Dori
  • AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT
    Publication number: 20130018081
    Abstract: Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.
    Type: Application
    Filed: January 16, 2012
    Publication date: January 17, 2013
    Inventors: Hermona Soreq, Raz Yirmiya, Amir Dori, Gal Ifergane, Michal Ivri
  • AChE antisense oligonucleotide as an anti-inflammatory agent
    Publication number: 20090005331
    Abstract: Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.
    Type: Application
    Filed: April 18, 2007
    Publication date: January 1, 2009
    Inventors: Hermona Soreq, Amir Dori, Itzhak Wirguin, Gal Ifergane, Raz Yirmiya
  • AChE antisense oligonucleotide as an anti-inflammatory agent
    Publication number: 20060069051
    Abstract: Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.
    Type: Application
    Filed: July 21, 2005
    Publication date: March 30, 2006
    Inventors: Hermona Soreq, Amir Dori, Itzhak Wirguin, Gal Ifergane, Raz Yirmiya